| [1] |
. J Chin Pharm Univ（中国药科大学学报）， 2019， 50（6）： 631-640.
|
| [2] |
Bruns C， Ober M. Development and preparation of oral suspensions for paediatric patients：a challenge for pharmacists［J］. Pharm Technol Hosp Pharm， 2018， 3（2）： 113-119.
|
| [3] |
Ip K， Shan A， Carvalho M， et al. Physicochemical stability of extemporaneously prepared oral suspension of fluconazole 50 mg/mL in SuspendltTM［J］. Pharm Technol Hosp Pharm， 2018， 3（2）： 101-112.
|
| [4] |
Bellay R， Bonnaure AC， Rault P， et al. Stability of 5 mg/mL nitrendipine oral suspension in Syrspend? SF PH4［J］. Pharm Technol Hosp Pharm， 2018， 3（1）： 31-37.
|
| [5] |
Polonini H， da Silva SL， Cunha CN， et al. Stability of azathioprine， clonidine hydrochloride， clopidogrel bisulfate， ethambutol hydrochloride， griseofulvin， hydralazine hydrochloride， nitrofurantoin， and thioguanine oral suspensions compounded with Syrspend SF PH4［J］. Int J Pharm Compd， 2020， 24（3）： 252-262.
|
| [6] |
Polonini H， da Silva SL， Brand?o MAF， et al. Compatibility of baclofen， carvedilol， hydrochlorothiazide， mercaptopurine， methadone hydrochloride， oseltamivir phosphate， phenobarbital， propranolol hydrochloride， pyrazinamide， sotalol hydrochloride， spironolactone， tacrolimus monohydrate， ursodeoxycholic acid， and vancomycin hydrochloride oral suspensions compounded with Syrspend SF PH4［J］. Int J Pharm Compd， 2018， 22（6）： 516-526.
|
| [7] |
Yang QU， Meng X， Liu D， et al. Fabrication and in vitro and in vivo evaluation of a novel bromine-resinate sustained release suspensions［J］. Latin Am J Pharm， 2018， 37（11）： 2211-2222.
|
| [8] |
Teresk MG， Berkland CJ， Dormer NH. Deficiencies in traditional oral dosage forms and the emergence of controlled- release powder manufacturing［J］. Kona Powder Part J， 2017， 34： 91-105.
|
| [9] |
Oz UC， Devrim B， Bozk?r A， et al. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery［J］. J Microencapsul， 2015， 32（4）： 317-328.
|
| [10] |
Rauf A， Kanwal U， Bukhari NI， et al. Development and characterization of taste masked ampicillin microspheres for pediatric oral use［J］. Latin Am J Pharm， 2018， 37（2）： 321-329.
|
| [11] |
Cirri M， Mennini N， Maestrelli F， et al. Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics［J］. Int J Pharm， 2017， 521（1/2）： 73-83.
|
| [12] |
Cirri M， Maestrelli F， Mura P， et al. Combined approach of cyclodextrin complexation and nanostructured lipid carriers for the development of a pediatric liquid oral dosage form of hydrochlorothiazide［J］. Pharmaceutics， 2018， 10（4）： 287.
|
| [13] |
Cirri M， Maestrini L， Maestrelli F， et al. Design， characterization and in vivo evaluation of nanostructured lipid carriers （NLC） as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy［J］. Drug Deliv， 2018， 25（1）： 1910-1921.
|
| [14] |
Aher SS， Malsane ST， Saudagar RB. Nanosuspension： an overview［J］. Int J Curr Pharm Res， 2017， 9（3）： 19-23.
|
| [15] |
Gonzalez MA， Ramírez Rigo MV， Gonzalez Vidal NL. Orphan formulations in pediatric schistosomiasis treatment： development and characterization of praziquantel nanoparticle-loaded powders for reconstitution［J］. AAPS PharmSciTech， 2019， 20（8）： 318.
|
| [16] |
Manyarara TE， Star K， Admire D， et al. Formulation and characterization of a paediatric nanoemulsion dosage form with modified oral drug delivery system for improved dissolution rate of nevirapine［J］. Mrs Adv， 2018， 3（37）： 2203-2219.
|
| [17] |
Halicki PCB， H?drich G， Boschero R， et al. Alternative pharmaceutical formulation for oral administration of rifampicin［J］. Assay Drug Dev Technol， 2018， 16（8）： 456-461.
|
| [18] |
Dai Q， Zhang P， Jin Y， et al. Using self-nanoemulsifying system to improve oral bioavailability of a pediatric antiepileptic agent stiripentol： formulation and pharmacokinetics studies［J］. AAPS PharmSciTech， 2020， 21（5）： 192.
|
| [19] |
Abouhussein DMN， Mahmoud D BED， Mohammad FE. Design of a liquid nano-sized drug delivery system with enhanced solubility of rivaroxaban for venous thromboembolism management in paediatric patients and emergency cases［J］. J Liposome Res， 2019， 29（4）： 399-412.
|
| [20] |
Soulele K， Macheras P. Milk as a medium for pediatric formulations： experimental findings and regulatory aspects［J］. Int J Pharm， 2015， 492（1/2）： 344-345.
|
| [21] |
Boyd BJ， Salim M， Clulow AJ， et al. The impact of digestion is essential to the understanding of milk as a drug delivery system for poorly water soluble drugs［J］. J Control Release， 2018， 292： 13-17.
|
| [22] |
Gerrard SE， Orlu-Gul M， Tuleu C， et al. Modeling the physiological factors that affect drug delivery from a nipple shield delivery system to breastfeeding infants［J］. J Pharm Sci， 2013， 102（10）： 3773-3783.
|
| [23] |
Flynn AD， Scheuerle RL， Galgon G， et al. Community feedback on the JustMilk Nipple Shield Delivery System in the Vhembe District of Limpopo Province， South Africa［J］. South Afr J Child Health， 2017， 11（4）： 192-197.
|
| [24] |
Lopez FL， Ernest TB， Tuleu C， et al. Formulation approaches to pediatric oral drug delivery： benefits and limitations of current platforms［J］. Expert Opin Drug Deliv， 2015， 12（11）： 1727-1740.
|
| [25] |
Rajabalaya R， Musa MN， Kifli N， et al. Oral and transdermal drug delivery systems： role of lipid-based lyotropic liquid crystals［J］. Drug Des Devel Ther， 2017， 11： 393-406.
|
| [26] |
Fan YL， Chen H， Huang ZW， et al. Taste-masking and colloidal-stable cubosomes loaded with cefpodoxime proxetil for pediatric oral delivery［J］. Int J Pharm， 2020， 575： 118875.
|
| [27] |
Petrovick GF， Breitkreutz J， Pein-Hackelbusch M. Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization［J］. Int J Pharm， 2016， 506（1/2）： 361-370.
|
| [28] |
Shen L， Zhang YD， Zhang JL， et al. Reversed lipid-based nanoparticles dispersed in iodized oil for transarterial chemoembolization［J］. ACS Appl Mater Interfaces， 2019， 11（23）： 20642-20648.
|
| [29] |
Zhang YD， Shen L， Wang T， et al. Taste masking of water-soluble drug by solid lipid microspheres： a child-friendly system established by reversed lipid-based nanoparticle technique［J］. J Pharm Pharmacol， 2020， 72（6）： 776-786.
|
| [30] |
Omar SM， Ibrahim F， Ismail A. Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste［J］. Saudi Pharm J， 2020， 28（3）： 349-361.
|
| [31] |
Hijazi Vega M， Cavada-Carranza I， Hernán-Moreno N， et al. 5PSQ-097 Potentially harmful excipients in neonatal and paediatric patients［J］. Eur J Hosp Pharm，， 2020， 27： A194.
|
| [32] |
Binson G， Beuzit K， Migeot V， et al. Preparation and physicochemical stability of liquid oral dosage forms free of potentially harmful excipient designed for pediatric patients［J］. Pharmaceutics， 2019， 11（4）： 190.
|
| [33] |
Barbosa R， Capela A， Sampaio C， et al. 3PC-028 Compounding an oral liquid formulation of diazepam alcohol free［J］. Eur J Hosp Pharm， 2020， 27： A34-A35.
|
| [34] |
Valeur KS， Hertel SA， Lundstr?m KE， et al. Safe excipient exposure in neonates and small children - protocol for the SEEN project［J］. Dan Med J， 2017， 64（2）： A5324.
|
| [35] |
Engels MJ， Ciarkowski SL， Rood J， et al. Standardization of compounded oral liquids for pediatric patients in Michigan［J］. Am J Health Syst Pharm， 2016， 73（13）： 981-990.
|
| [36] |
Suárez-González J， Santove?a-Estévez A， Armijo-Ruíz S， et al. A high-demanding strategy to ensure the highest quality standards of oral liquid individualized medicines for pediatric use［J］. AAPS PharmSciTech， 2019， 20（5）： 208.
|
| [37] |
Davis SJ， Hurtado J， Nguyen R， et al. Innovations in medication preparation safety and wastage reduction： use of a workflow management system in a pediatric hospital［J］. Hosp Pharm， 2017， 52（1）： 54-59.
|
| [38] |
Bledsoe S， Van Buskirk A， Falconer RJ， et al. Errors detected in pediatric oral liquid medication doses prepared in an automated workflow management system［J］. Am J Health Syst Pharm， 2018， 75（3）： 127-131.
|
下载:
